Diabetes mellitus (DM), which is considered a public health threat, affects various organs and results in different vascular and non-vascular complications. The prevalence of DM is showing a significant upward trend worldwide in recent years [1]. In 2015, more than 410 million people were estimated as being diabetic; by 2040, this number is predicted to outweigh 640 million, with rising disproportionately in low- to middle-income countries [2] with an increasingly aging population and global obesity pandemic is the urging trigger behind the rising occurrence of diabetes [3] [4]. The most current national proportion of diabetic adults in the United States is 12.2% [5]. The total estimated occurrence of diabetes in China in 2017 was approximately 13% using the ADA criteria for diagnosis and around 11% according to World Health Organization criteria [6]. As reported by the diabetes atlas of the IDF, the world’s largest diabetic population resides in China. Estimations indicate that China has 113.9 million adults living with diabetes, making almost one-fourth of all diabetes patients globally [7].

Type 2 diabetes mellitus is one of the most relevant risk factors for CKD development; approximately 30% - 50% of ESRD patients come from a diabetic origin [8].

Diabetic nephropathy is causing an increase in the number of patients with ESKD as a result of a steady rise in the prevalence of diabetes mellitus (DM); especially type 2 DM, which is ten times more prevalent than type 1, as well as an increase in the life expectancy of diabetic patients who develop such late complications [9]. The underlying pathogenetic components of the onset and development of renal injury in diabetic nephropathy are multifactorial. Renal hemodynamic abnormalities, such as increased glomerular filtration rate (GFR), hydrostatic capillary pressure, and persistent hyperglycemia, cause biochemical shifts in the polyol pathway and contribute to the production of advanced nonenzymatic glycosylation products, are among them [10]. However, new evidence is emerging that the immune response represents a crucial impact on diabetic nephropathy progression [8]. Although each cell type in the glomerular tuft is damaged by diabetic nephropathy, damage to podocytes is considered as a key to the advancement of glomerulosclerosis [11] [12]. DN is not the isolated type of kidney damage in diabetic patients, as other damage types apart from diabetic nephropathy are accumulatively considered a non-diabetic renal disease (NDRD) [13]. In documented studies [1] [13] - [27], the prevalence of biopsy-proven NDKD in T2DM varies greatly, varying between 8% [14] and 93.5% [15]. This percentage is based on the population examined and selected for kidney biopsy, together with the accessibility of renal biopsy. NDRD, compared to DN, includes a wide range of kidney injuries. Among DN and NDRD, there are important clinical, pathological features and prognostic heterogeneity. The clinical and pathological diagnosis of these diseases does have a major impact on the treatment options available and the patients’ renal prognosis. Even so, there is no uniformity in the way these patients are diagnosed. Diagnosis of DN commonly depends on clinical signs and is supported by the presence of hypertension, persistent proteinuria, and continuous decrease in renal functionality [28], whilst the kidney biopsy is not absolutely compulsory. Patients affected by NDRD, in contrast remain misdiagnosed.

Treatment approaches of DN and NDRD differ noticeably. It has been widely assumed that DN reversal is hard to achieve. On the other hand, some forms of NDRD are easily curable and even remittable. To the common knowledge, kidney biopsy is the most crucial diagnostic tool in differentiating DN and NDRD. Although the procedure of renal biopsy is accompanied by complications, such as relatively large trauma and bleeding, it is usually recommended to do a renal biopsy in patients matching NDRD indications. Nevertheless, there is still controversy whether it is important to perform kidney biopsy if patients with diabetes represent more kidney disease-related symptoms. Therefore, further research is required to identify NDRD predictors.

The current study was designed to determine the occurrence and type of non- diabetic renal disease diagnosed by kidney biopsy in type 2 diabetic patients, examine possible association of clinical and laboratory parameters with histopathology findings, as well as identifying essential predictors of NDRD.

This study enrolled 101 type-two diabetic patients. The median age at biopsy was 51.2 ± 10.9 years, 41% of the patients (41) were female, and the average duration of diabetes was four years (varying between 1 month and 300 months). Table 1 summarizes baseline clinical and laboratory parameters of patients.

As reported by kidney biopsy, NDRD was found in 59 patients (58.42%), while isolated DN was diagnosed in 32 patients (31.68%), and DN complicated with NDRD was present in the remaining ten patients (9.90%). As indicated in Table 2, focal segmental glomerulosclerosis (FSGS) was found in 8 patients (11.6%) and IgA nephropathy in 7 patients (10.1%), while membranous nephropathy, which was diagnosed in 29 patients (42%), remained the most prevalent NDRD.

Moreover, univariate analysis of primary classification groups (DN vs. NDRD vs. mixed lesions (in Table 1) revealed a significant variation in terms of age (p < 0.030), diabetes duration (p < 0.001), and hemoglobin (p < 0.006). Alongside

*p < 0.05 (ANOVA/Kruskal-Wallis-test/χ²-test/Fisher’s-test). FBG, fasting blood glucose; GFR, glomerular filtration rate; DN, diabetic nephropathy; NDRD, Non-diabetic renal disease; MIX, NDRD superimposed on DN.

NDRD, non-diabetic renal disease; MIX, NDRD superimposed on diabetic nephropathy.

the used univariate analysis also revealed that subjects with NDRD had older age (p < 0.018), shorter duration of diabetes (p < 0.000), lower proteinuria (p < 0.030), and had higher hemoglobin levels (p < 0.006) compared to non-NDRD patients, as shown in (Table 3).

To identify risk factors for NDRD, multivariate (binary) logistic regression analysis was performed, and variables considered statistically significant in univariate analysis were included. The findings are outlined in Table 4.

We also found that the short diabetes duration (OR 0.986; 95% CI = 0.978 - 0.993; p = 0.000) and older age (OR 1.080; 95% CI = 1.028 - 1.134; p = 0.002) were significant NDRD risk factors. The sensitivity and specificity of risk factors associated with NDRD were evaluated using ROC analysis, and the results are shown in Table 5.

Table 5 Sensitivity, Specificity, Positive and Negative Predictive Values of Significant Variables in The Prediction of Diabetic Kidney Disease and of Non- Diabetic Renal Disease.

The duration of diabetes less than or equal to 78 months (cut-off value (0.725, 0.313)) showed the highest AUC for NDRD. Figure 1 illustrates the AUC curves for the predictors of NDRD.

*p < 0.05 (ANOVA/Mann-Whitney-test/χ²-test/Fisher’s-test). FBG, fasting blood glucose; GFR, glomerular filtration rate; DN, diabetic nephropathy; NDRD, non-diabetic renal disease; MIX, NDRD superimposed on DN.

NDRD, non-diabetic renal disease; OR, odds ratio; CI, confidence interval.

NDRD, non-diabetic renal disease; AUC, area under curve; PPV, positive predictive value; NPV, negative predictive Value.

Diabetic nephropathy (DN) is the dominant reason for end-stage kidney disease and correlates with a higher cardiovascular mortality rate [8]. However, Diabetic nephropathy is not the sole kidney pathology seen in patients with type 2 diabetes; a wide range of non-diabetic renal disease (NDRD), comprising both glomerular and tubulointerstitial invasions, may still present [34]. Previous studies [1] [13] - [27] [34] - [38] demonstrated that the prevalence of biopsy-proven NDKD in T2DM varies greatly, ranging from 8% [14] to 93.5% [15]. In our study, the prevalence was 68.32%, most similar to Wilfred et al.’s findings [23]. The disparity in the prevalence of NDRD could be explained through demographic variations of participants included as well as dissimilar indications for biopsy. In current study, patients undergoing renal biopsy were defined by using prevalent indications which can be seen in other similar studies, namely, proteinuria [1] [13] [15] [16] [20], rapidly progressive renal failure [1] [15] [16] [17] [19] [24], glomerular hematuria [15] [18] [20] [24], absence of diabetic retinopathy [13] [15] [18] [19] [35] and shorter duration of diabetes [15] [16] [36] [39].

In our study, glomerulonephritis was the most prevalent type of NDRD, being similar to findings of majority studies [13] [15] [16], while interstitial nephritis was defined as prevailing NDRD according to some researches [16] [20]. We found that membranous nephropathy 29 (42%) was the most prevalent NDRD, followed by focal segmental-glomerulosclerosis 8 (11.6%), IgA Nephropathy 7 (10.1%), minimal change disease 6 (8.7%), tubulointerstitial Nephritis 5 (7.3%), renal amyloidosis 2 (2.9%), lupus nephritis 2 (2.9%), hypertensive renal damage 2 (2.9%) cases.

It is also noteworthy that, besides regional and ethnic variations, different approaches to renal pathological diagnosis may impact the pathological distribution of NDRD in diabetic patients. For instance, focal segmental glomerulosclerosis, IgA nephropathy, and membranoproliferative glomerulonephritis were the most prevalent type of NDRD in the USA, Korea, as well as in Iraq, while acute interstitial nephritis and post-infectious glomerulonephritis were identified more often in India [27].

Since NDRD requires additional treatment and poses an opportunity for renal function preservation, its detection remains principal [37]. Although renal biopsy is approximately the only tool that can definitively distinguish DN from NDRD, identification of NDRD related prognostic factors prior to biopsy is critical. Clinical parameters, such as shorter duration of diabetes, older age, lower proteinuria, and higher hemoglobin level were identified as significant predictors of NDRD in univariate analysis (NDRD vs. non-NDRD). However, only the duration of diabetes less than or equal to 78 months and age greater than or equal to 50.5 years were statistically significant independent risk factors of NDRD when multivariate analysis was performed.

Previous studies have identified the short diabetes duration as being a significant predictor of NDRD through univariate or multivariate analysis [17] [21] [22] [23] [38] [40]. Thus, our findings further support the concept that short diabetes duration may hint at the presence of NDRD and necessitate kidney biopsy. In our study, the sensitivity and specificity of the short duration of diabetes in predicting NDRD was found to be 72.46% and 68.75%, respectively; these results were comparable to the ones reported by Tone et al. discovered with the sensitivity and specificity of 75% and 70%, respectively [21].

Previously, some studies identified older age being a risk factor of NDRD presence [26] [40]. In our study, the sensitivity and specificity of older age in predicting NDRD was found to be 62.32% and 62.50%, respectively. This predictor’s sensitivity and specificity have never been reported in published studies. Certainly, the association between the short duration of diabetes and NDRD was likely. However, the possibility of older age in diabetic patients as an NDRD risk factor has also been suggested by our findings. Thus, it may be reasonable to perform a renal biopsy in the case of suspicion, even in elderly diabetic patients.

In this study, we have not identified any other clinical or laboratory variable that was a statistically significant predictor of NDRD in multivariate analysis, although higher hemoglobin levels were significantly associated with NDRD in univariate analysis. Similarly, the significant findings illustrating the higher hemoglobin levels as NDRD predictor has not been found in other studies, except findings of Chang et al. [17] and M. Liu et al. [41], which also discovered statistical significance in multivariate analysis. It has been assumed that in patients with NDRD, hemoglobin level may correlate with lower serum creatinine levels. Moreover, anemia may occur earlier in patients suffering from diabetic nephropathy compared to patients with non-diabetic glomerular disease, and similar renal function may somehow result in this independent predictive power of the hemoglobin level on NDRD [42]. However, some studies have suggested that diabetic patients are generally affected by visceral nerve innervation disorders that potentially may cause defective erythropoietin (EPO) secretion. This evidence may support the significantly higher possibility of associated anemia in diabetic patients [43] [44].

Lower proteinuria, which had statistical significance in our univariate analysis, was also identified as significant predictors of NDRD in other research (Bi, H. et al.) [20].

Identifying and monitoring DN is based on evaluations of renal function, generally with an estimated GFR (eGFR) of <60 mL/min/1.73m² and renal damage, generally with albuminuria > 30 mg/g creatinine [45]. Several previous studies found that a long duration of diabetes may correlate with DN [16] [22]. In combination with this study results, the duration of diabetes mellitus is a significant predictor for NDRD and DN identification.

The main limitations of the current study include the following: it was a retrospective and monocentric study. Thus, biases in patient selection might lead to ascertainment error, recall, or lead-time biases. Even though only type 2 diabetic patients with a high suspicion of NDRD were enrolled, biases in the patient selection are another limitation of our study. As demonstrated, there was significant heterogeneity in the criteria used to conduct a renal biopsy, highlighting the importance of identifying clinical predictors of NDRD. The recognized NDRD indications were chosen as the criteria for renal biopsy. Furthermore, the anti-phospholipase A2 receptor antibody and body mass index were excluded from the analysis considering the high percentage of missed values. However, these limitations might make it difficult to draw definitive conclusions for the entire diabetic population.

To conclude, clinical parameters such as short duration of diabetes, older age, higher hemoglobin level, and lower proteinuria might be associated with NDRD in type 2 diabetic patients. Early diagnosis of NDRD poses a favorable renal prognosis because it requires a different approach than DN, further larger multicenter randomized prospective investigations focused on identifying possible risk markers of NDRD are still in priority.

Conceptualization, methodology, formal analysis, writing—original draft preparation, A.M.M.; data curation, formal analysis, N.X.; resources, Conceptualization, G.L.; writing—review and editing, software, formal analysis, B.O.; resources, visualization, B.J.; Conceptualization, supervision, project administration, funding acquisition, Z.H.

The authors declare no conflicts of interest.

Mohamud, A.M., Xu, N., Liu, G.Y., Odilov, B., Jiang, B. and Hu, Z. (2022) The Spectrum of Kidney Disease in Type Two Diabetic Patients: A Single-Center Study. Open Journal of Nephrology, 12, 1-14. https://doi.org/10.4236/ojneph.2022.121001